Skenes' ERA Collapse Masks a More Durable Problem: Fly-Ball Management

Paul Skenes' last dominant outing arrived on May 12 at home against Colorado—eight shutout innings, two hits, ten strikeouts, nothing on the board. That was 56 days ago. Since that date, Skenes has worked 47 innings with a 5.36 ERA, dipped below six innings in six of his nine starts, and surrendered seven of his 11 season home runs. The narrative has hardened fast: the Cy Young winner has lost his command, his health, or both.

But the expected-stats picture complicates the obituary. Skenes' ERA sits at 3.62 for the season; his xERA is 2.76. That gap—0.86 runs—marks the first time in his career his underlying metrics outpace his actual results by a meaningful margin. For comparison, in his first two major-league seasons combined, he outperformed his xERA by just over a half-run. The culprit isn't strikeout velocity or spin rate deterioration. It's batted-ball sequencing and Pittsburgh's defense imploding behind him. The Pirates have posted minus-7 fielding runs with Skenes on the mound (worst in baseball), and minus-five of those losses came during this recent nine-start skid. Two glaring plays—Oneil Cruz losing a fly ball in the sun on Opening Day, Nick Gonzales' errant throw on a bases-loaded grounder last week—captured the organizational dysfunction, but the data confirms it's systemic.

The home-run spike, however, represents a real mechanical or approach issue, not pure luck. Skenes' HR/FB ratio has climbed to 14.3% over his last nine starts and 10.8% for the season—a sharp departure from his 6.3% mark in 2025. FIP and xFIP largely align with his actual results, which means the elevated fly-ball damage rate is his problem to solve, not an artifact of fielding luck. The context matters: only six pitchers in the past decade with 160+ innings have sustained a sub-9% HR/FB rate across multiple seasons. Skenes was never going to repeat 6.3%. But 14.3% is regression with teeth, not regression toward league average.

For bettors, this split diagnosis creates an edge. Skenes' strikeout rate has remained stable (9.8 K/9 this season, 10.1 career), meaning his K props are priced fairly—no grab here. His ERA line, though, sits artificially high because books have likely overweighted the recent nine-start disaster. If Pittsburgh's defense even marginally improves, or if he adjusts his fly-ball approach (pulling fewer fastballs up in the zone to damaged-ball hitters), his actual ERA will compress toward that xERA floor of 2.76. That's a 0.86-run gap—large enough to exploit early in his next start, before the market adjusts. The next matchup and park environment matter enormously; a favorable BABIP situation could make unders on his ERA line within 3.50–3.75 range undervalued for his next two to three starts.

The cautionary note: if the mechanical issue is a shoulder or elbow problem masquerading as a fly-ball epidemic, the situation reverses entirely. Skenes hasn't disclosed any injury, and recent reports don't flag physical setback. Until that changes, the bet is on environmental recovery—a cleaner defense and a marginally sharper approach—not a miraculous return to 2025 form.